Structure-Guided Engineering of Cytotoxic Cabazitaxel for an Adaptive Nanoparticle Formulation: Enhancing the Drug Safety and Therapeutic Efficacy
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Structure-Guided Engineering of Cytotoxic Cabazitaxel for an Adaptive Nanoparticle Formulation: Enhancing the Drug Safety and Therapeutic Efficacy
Authors
Keywords
-
Journal
ADVANCED FUNCTIONAL MATERIALS
Volume 28, Issue 52, Pages 1804229
Publisher
Wiley
Online
2018-11-09
DOI
10.1002/adfm.201804229
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dual-Drug Delivery Using Dextran-Functionalized Nanoparticles Targeting Cardiac Fibroblasts for Cellular Reprogramming
- (2018) Mónica P. A. Ferreira et al. ADVANCED FUNCTIONAL MATERIALS
- Tumor Inhibition Achieved by Targeting and Regulating Multiple Key Elements in EGFR Signaling Pathway Using a Self-Assembled Nanoprodrug
- (2018) Bowen Li et al. ADVANCED FUNCTIONAL MATERIALS
- Semiconducting Polymer Nanoenzymes with Photothermic Activity for Enhanced Cancer Therapy
- (2018) Jingchao Li et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Enhanced oral absorption and anticancer efficacy of cabazitaxel by overcoming intestinal mucus and epithelium barriers using surface polyethylene oxide (PEO) decorated positively charged polymer-lipid hybrid nanoparticles
- (2018) Tianyang Ren et al. JOURNAL OF CONTROLLED RELEASE
- A Tumor-Activatable Theranostic Nanomedicine Platform for NIR Fluorescence-Guided Surgery and Combinatorial Phototherapy
- (2018) Xiaoning Li et al. Theranostics
- Evaluation of cabazitaxel's toxicity and tolerance: AC Camargo Cancer Center experience.
- (2017) Christiane Silveira Marinho Albuquerque et al. JOURNAL OF CLINICAL ONCOLOGY
- Cabazitaxel Versus Docetaxel As First-Line Therapy for Patients With Metastatic Castration-Resistant Prostate Cancer: A Randomized Phase III Trial—FIRSTANA
- (2017) Stéphane Oudard et al. JOURNAL OF CLINICAL ONCOLOGY
- EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
- (2017) Tsukasa Shibue et al. Nature Reviews Clinical Oncology
- Cancer Nanomedicines Stabilized by π-π Stacking between Heterodimeric Prodrugs Enable Exceptionally High Drug Loading Capacity and Safer Delivery of Drug Combinations
- (2017) Hangxiang Wang et al. Theranostics
- Targeted Delivery of Cabazitaxel by Conjugation to Albumin-PEG-folate Nanoparticles Using a Cysteine-acrylate Linker and Simple Synthesis Conditions
- (2017) Mohammad Kazem Khoeeniha et al. Current Drug Delivery
- Rethinking cancer nanotheranostics
- (2017) Hongmin Chen et al. Nature Reviews Materials
- Cabazitaxel or mitoxantrone with prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel: Final results of a multinational phase III trial (TROPIC).
- (2017) J. S. De Bono et al. JOURNAL OF CLINICAL ONCOLOGY
- Well-Defined Polymer-Paclitaxel Prodrugs by a Grafting-from-Drug Approach
- (2016) Benoit Louage et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Redox-Sensitive Citronellol–Cabazitaxel Conjugate: Maintained in Vitro Cytotoxicity and Self-Assembled as Multifunctional Nanomedicine
- (2016) Peng Xue et al. BIOCONJUGATE CHEMISTRY
- Mild photothermal therapy/photodynamic therapy/chemotherapy of breast cancer by Lyp-1 modified Docetaxel/IR820 Co-loaded micelles
- (2016) WenTing Li et al. BIOMATERIALS
- Oligo(lactic acid)n-Paclitaxel Prodrugs for Poly(ethylene glycol)-block-poly(lactic acid) Micelles: Loading, Release, and Backbiting Conversion for Anticancer Activity
- (2016) Yu Tong Tam et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Improved i.p. drug delivery with bioadhesive nanoparticles
- (2016) Yang Deng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Augmenting drug–carrier compatibility improves tumour nanotherapy efficacy
- (2016) Yiming Zhao et al. Nature Communications
- Complete Regression of Xenograft Tumors upon Targeted Delivery of Paclitaxel via Π–Π Stacking Stabilized Polymeric Micelles
- (2015) Yang Shi et al. ACS Nano
- Self-Assembling Prodrugs by Precise Programming of Molecular Structures that Contribute Distinct Stability, Pharmacokinetics, and Antitumor Efficacy
- (2015) Hangxiang Wang et al. ADVANCED FUNCTIONAL MATERIALS
- Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2015) C. Parker et al. ANNALS OF ONCOLOGY
- Nanoparticle targeting of anti-cancer drugs that alter intracellular signaling or influence the tumor microenvironment
- (2014) Mathumai Kanapathipillai et al. ADVANCED DRUG DELIVERY REVIEWS
- Structure-Based Rational Design of Prodrugs To Enable Their Combination with Polymeric Nanoparticle Delivery Platforms for Enhanced Antitumor Efficacy
- (2014) Hangxiang Wang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- CCL20 and CXCL8 synergize to promote progression and poor survival outcome in patients with colorectal cancer by collaborative induction of the epithelial–mesenchymal transition
- (2014) Xian-Shuo Cheng et al. CANCER LETTERS
- Influence of Drug Formulation on OATP1B-Mediated Transport of Paclitaxel
- (2014) A. J. M. Nieuweboer et al. CANCER RESEARCH
- Sustained-release from nanocarriers: a review
- (2014) Jayaganesh V. Natarajan et al. JOURNAL OF CONTROLLED RELEASE
- Targeting EMT in cancer: opportunities for pharmacological intervention
- (2014) Felicity M. Davis et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Mesoporous Magnetic Gold “Nanoclusters” as Theranostic Carrier for Chemo-Photothermal Co-therapy of Breast Cancer
- (2014) JinRong Peng et al. Theranostics
- Y-Shaped mPEG-PLA Cabazitaxel Conjugates: Well-Controlled Synthesis by Organocatalytic Approach and Self-Assembly into Interface Drug-Loaded Core–Corona Nanoparticles
- (2013) Fethi Bensaid et al. BIOMACROMOLECULES
- Real-world cabazitaxel safety: the Italian early-access program in metastatic castration-resistant prostate cancer
- (2013) Sergio Bracarda et al. Future Oncology
- The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
- (2012) Hiroshi Maeda et al. ADVANCED DRUG DELIVERY REVIEWS
- Cabazitaxel: More Than a New Taxane for Metastatic Castrate-Resistant Prostate Cancer?
- (2012) A. C. Mita et al. CLINICAL CANCER RESEARCH
- A docetaxel-carboxymethylcellulose nanoparticle outperforms the approved taxane nanoformulation, Abraxane, in mouse tumor models with significant control of metastases
- (2012) Mark J. Ernsting et al. JOURNAL OF CONTROLLED RELEASE
- Preclinical pharmacokinetic, biodistribution, and anti-cancer efficacy studies of a docetaxel-carboxymethylcellulose nanoparticle in mouse models
- (2011) Mark J. Ernsting et al. BIOMATERIALS
- Chemical Cell-Surface Receptor Engineering Using Affinity-Guided, Multivalent Organocatalysts
- (2011) Hangxiang Wang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Time for a Pause
- (2011) S. M. Hurtley Science Signaling
- Tumor delivery of macromolecular drugs based on the EPR effect
- (2010) Vladimir Torchilin ADVANCED DRUG DELIVERY REVIEWS
- Cabazitaxel for the treatment of castration-resistant prostate cancer
- (2010) Neeraj Agarwal et al. Future Oncology
- Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
- (2010) Johann Sebastian de Bono et al. LANCET
- Cabazitaxel
- (2010) Matthew D. Galsky et al. NATURE REVIEWS DRUG DISCOVERY
- EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
- (2010) A Singh et al. ONCOGENE
- Preclinical and clinical studies of anticancer agent-incorporating polymer micelles
- (2009) Yasuhiro Matsumura et al. CANCER SCIENCE
- Phase I and Pharmacokinetic Study of XRP6258 (RPR 116258A), a Novel Taxane, Administered as a 1-Hour Infusion Every 3 Weeks in Patients with Advanced Solid Tumors
- (2009) A. C. Mita et al. CLINICAL CANCER RESEARCH
- In vivo antitumor effects of chitosan-conjugated docetaxel after oral administration
- (2009) Eunhye Lee et al. JOURNAL OF CONTROLLED RELEASE
- Synthetic polymeric nanoparticles by nanoprecipitation
- (2009) Stephanie Hornig et al. JOURNAL OF MATERIALS CHEMISTRY
- Ring-Opening Polymerization-Mediated Controlled Formulation of Polylactide−Drug Nanoparticles
- (2009) Rong Tong et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Self-assembling chimeric polypeptide–doxorubicin conjugate nanoparticles that abolish tumours after a single injection
- (2009) J. Andrew MacKay et al. NATURE MATERIALS
- Paclitaxel-Initiated, Controlled Polymerization of Lactide for the Formulation of Polymeric Nanoparticulate Delivery Vehicles
- (2008) Rong Tong et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- A multicenter phase II study of XRP6258 administered as a 1-h i.v. infusion every 3 weeks in taxane-resistant metastatic breast cancer patients
- (2008) X. Pivot et al. ANNALS OF ONCOLOGY
- Nanoparticle formulations in pulmonary drug delivery
- (2008) Mark M. Bailey et al. MEDICINAL RESEARCH REVIEWS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now